Orthofix Medical Inc. President Reinhardt Max sells 1643 shares at $11.64 on June 11.
PorAinvest
viernes, 13 de junio de 2025, 4:27 pm ET1 min de lectura
OFIX--
The sale of shares by a high-ranking executive can sometimes influence market perception, but in this case, the transaction was specifically for tax purposes. The stock price of OFIX has been volatile in recent days, with shares falling 2.90% in mid-day trading on June 12, 2025. The stock reached an intraday low of $10.95 before recovering slightly to $11.05, down from its previous close of $11.38 [2]. This places OFIX 46.70% below its 52-week high of $20.73 and 5.24% above its 52-week low of $10.50 [2].
Wall Street analysts have forecasted an average target price for OFIX of $24.40, with a high estimate of $27.20 and a low estimate of $22.00 [2]. This suggests an average upside of 120.81% from the current price of $11.05. The consensus recommendation from brokerage firms is "Outperform" [2]. GuruFocus estimates the GF Value for OFIX to be $16.84 in one year, suggesting an upside of 52.4% from the current price of $11.05 [2].
References:
[1] https://www.tradingview.com/news/tradingview:69a163b7c2904:0-orthofix-medical-officer-sells-shares-to-cover-tax-obligations/
[2] https://www.gurufocus.com/news/2924698/orthofix-medical-inc-ofix-stock-price-down-29-on-jun-12
Orthofix Medical Inc. (OFIX) has reported that President, Global Spine Reinhardt Max has divested 1643 shares at a price of $11.64 per share on June 11, 2025.
Orthofix Medical Inc. (OFIX) has reported that its President of Global Spine, Max Reinhardt, sold 1,643 shares of common stock on June 11, 2025, at a price of $11.64 per share, totaling $19,124 [1]. This transaction was to satisfy tax withholding obligations related to the settlement of restricted stock units, as mandated by the company's Compensation and Talent Development Committee. Following this sale, Reinhardt directly owns 27,481 shares of Orthofix Medical, including 24,324 restricted stock units previously reported [1].The sale of shares by a high-ranking executive can sometimes influence market perception, but in this case, the transaction was specifically for tax purposes. The stock price of OFIX has been volatile in recent days, with shares falling 2.90% in mid-day trading on June 12, 2025. The stock reached an intraday low of $10.95 before recovering slightly to $11.05, down from its previous close of $11.38 [2]. This places OFIX 46.70% below its 52-week high of $20.73 and 5.24% above its 52-week low of $10.50 [2].
Wall Street analysts have forecasted an average target price for OFIX of $24.40, with a high estimate of $27.20 and a low estimate of $22.00 [2]. This suggests an average upside of 120.81% from the current price of $11.05. The consensus recommendation from brokerage firms is "Outperform" [2]. GuruFocus estimates the GF Value for OFIX to be $16.84 in one year, suggesting an upside of 52.4% from the current price of $11.05 [2].
References:
[1] https://www.tradingview.com/news/tradingview:69a163b7c2904:0-orthofix-medical-officer-sells-shares-to-cover-tax-obligations/
[2] https://www.gurufocus.com/news/2924698/orthofix-medical-inc-ofix-stock-price-down-29-on-jun-12

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios